Guiding access from the very first step.
Hagemia Assist helps eligible patients complete the first steps of program enrollment, provide consent, and stay connected through their patient portal while their prescriber finalizes required documentation.
hageman-alpha injection
Recombinant Factor XII replacement therapy
Designed for patients with Factor XII Deficiency, Hagemia is positioned around the “Spark” of the intrinsic coagulation pathway.
Hagemia Assist helps simplify enrollment.
A patient-friendly workflow helps eligible patients begin enrollment, provide consent, and route the prescriber portion for completion.
Eligibility Assessment
Guided screening for patient support eligibility and required program criteria.
Patient Consent
Digital authorization to receive support services and program communications.
Prescriber Handoff
Enrollment form routing so the provider can complete clinical and prescription details.
Patient Portal Access
Visibility into enrollment status, documents, support updates, and future therapy activity.
Additional support resources
Explore educational materials and independent support resources that may help patients throughout their treatment journey.
Alternative Funding Resources
Patients may also explore independent non-profit organizations that provide financial assistance for eligible individuals, including travel support and treatment-related expenses.
Disease State Education
Learn more about Factor XII Deficiency and the “Spark of the Cascade” through patient-friendly educational content and guided learning materials.
Explore simplified visual explanations of the coagulation pathway, Factor XII activity, and treatment support information.